Ron Menezes serves as Chief Revenue Officer at The Beauty Health Company (NASDAQ: BHC), a global leader in beauty health technology renowned for its HydraFacial brand and innovative treatment devices. In this role, he spearheads worldwide revenue strategies, commercial operations, sales enablement, and key partnerships to accelerate growth, expand market penetration, and drive adoption of the company's advanced aesthetic solutions among professionals and consumers alike. With more than 25 years of expertise in the aesthetics, medical devices, and beauty industries, Ron brings a proven track record from senior leadership positions at industry giants. Prior to Beauty Health, he was Senior Vice President of North America Commercial Operations at Allergan Aesthetics (an AbbVie company), where he oversaw multibillion-dollar portfolios in facial injectables, energy-based devices, and body contouring, leading teams that achieved double-digit revenue growth through optimized sales infrastructures and market expansions. Earlier roles included executive positions at Ulthera (acquired by Merz Aesthetics), Syneron-Candela, and Lumenis, where he honed skills in global commercialization and product launches. Ron's achievements include scaling commercial organizations to generate over $3 billion in annual revenues, pioneering digital training platforms that boosted provider engagement, and fostering strategic alliances that propelled category leadership. His customer-centric approach and deep industry insights continue to fuel The Beauty Health Company's mission to redefine beauty health through scalable, results-driven innovations.